NORTH AMERICA COMPANION ANIMAL DRUGS MARKET ANALYSIS (2020-2027) - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

NORTH AMERICA COMPANION ANIMAL DRUGS MARKET ANALYSIS (2020-2027)

Description:

Read here the market research report on the “North America Companion Animal Drugs Market” published by CMI team – PowerPoint PPT presentation

Number of Views:6
Date added: 30 October 2020
Slides: 20
Provided by: kunalbhuta
Category:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: NORTH AMERICA COMPANION ANIMAL DRUGS MARKET ANALYSIS (2020-2027)


1
  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • COVID-19 Impact Tracker

2
NORTH AMERICA COMPANION ANIMAL DRUGS MARKET
ANALYSIS (2020-2027)
  • North America Companion Animal Drugs Market, By
    Product Type (Antibiotics, Anti-inflammatory,
    Parasiticides, Ecto-Parasiticides,
    Endo-Parasiticides, Heart worm Products,
    Behavioral Products, Nutritional Products, Skin
    care Products, Vaccines), By Distribution Channel
    (Veterinary Hospitals, Veterinary Clinics,
    Pharmacies and Drug Stores), and By Region (U.S.,
    Canada) - Size, Share, Outlook, and Opportunity
    Analysis, 2020 - 2027

3
  • A companion animal primarily refers to cats and
    dogs, which are domesticated and normally
    maintained in or near the household of the owner
    or person caring for them. Pet or companion
    animals do not refer to a farm animal, or grazing
    animals such as cattle and sheep.

4
  • Statistics
  • North America companion animal drugs market is
    estimated to account for US 14,065.8 Mn in terms
    of value by the end of 2027.

5
  • North America Companion Animal Drugs Market
    Drivers
  • Increasing adoption of companion animals is
    expected to propel growth of North America
    companion animal drugs market over the forecast
    period. For instance, according to 2017-2018 U.S.
    Pet Ownership Demographics Sourcebook of
    American Veterinary Medical Foundation (AVMF),
    38.4 of household in the U.S. owned dogs
    compared to 36.5 in 2012.
  • Moreover, increasing geriatric population is also
    expected to boost is demand for companion animal
    drugs. For instance, according to the U.S. Census
    Bureau, the U.S. geriatric population is expected
    to reach 77 million by 2034.   

6
  • Statistics
  • U.S. held dominant position in North America
    companion animal drugs market in 2019, accounting
    for 83.2 share in terms of value, followed by
    Canada respectively.

7
  • Figure 1 North America Companion Animal Drugs
    Market Share () Value, By Region, 2019

8
  • North America Companion Animal Drugs Market
    Restraints
  • High cost of animal healthcare services and lack
    of pet insurance is expected to hinder growth of
    North America companion animal drugs market. For
    instance the companion animal healthcare expenses
    include annual surgical vet visits costs of US
    474 for dogs, US 245 for cats, and US 45 for
    birds, sick vet visits costs (yearly average) of
    US 204 for dogs, US 244 for cats, and US 138
    for birds, and emergency vet visits costs (yearly
    average) of US 349 for dogs, US 154 for cats,
    US 107 for birds, and US 471 for horses.
  • Moreover, lack of awareness of animal diseases is
    also expected to limit the demand for companion
    animal drugs. In many developing countries,
    people lack awareness regarding certain serious
    companion animal diseases as opposed to livestock
    diseases, which are more regularly monitored.

9
(No Transcript)
10
  • North America Companion Animal Drugs Market
    Opportunities  
  • High prevalence of salmonella infection is
    expected to offer lucrative growth opportunities
    for players in North America companion animal
    drugs market. For instance, according to May 2019
    report of the Centers of Disease Control and
    Prevention (CDC), salmonella infection
    (salmonellosis) causes approximately 1.2 million
    illnesses and 450 deaths annually, in the U.S.
    and in 2018, there were 18 reported outbreaks, 15
    of which were linked to food.
  • Moreover, availability of online veterinary
    pharmacies is also expected to aid in growth of
    the market.

11
  • Statistics
  • North America companion animal drugs market was
    valued at US 10,384.2 Mn in 2019 and is forecast
    to reach a value of US 14,065.8 Mn by 2027 at a
    CAGR of 3.8 between 2020 and 2027.

12
  • Figure 2 North America Companion Animal Drugs
    Market Value (US Mn), 2016 2027

13
  • Market Trends/Key Takeaways 
  • Increasing number of exotic animals is expected
    to propel growth of North America companion
    animal drugs market. For instance, according to
    2017-2018 U.S. Pet Ownership Demographics
    Sourcebook of American Veterinary Medical
    Foundation (AVMF), the number of rabbits per
    1,000 households in the U.S increased from 1,408
    in 2012 to 1, 534 in 2017-2018.
  • Major players in North America companion animal
    drugs market are focused on launching new
    products to expand their product portfolio. For
    instance, in 2018, Dechra Veterinary Products,
    LLC launched new TAF Spray, a next generation
    antibiotic wound spray used for the treatment of
    wounds in animals.

14
  • North America Companion Animal Drugs Market
    Competitive Landscape
  • Major players operating in North America
    companion animal drugs market include, Zoetis
    Inc., Merck Co., Inc., Bayer AG, Eli Lily
    Co., Sanofi (Merial), Ceva Santé Animal, Virbac
    Animal Health, and Boehringer Ingelheim GmbH.

15
  • North America Companion Animal Drugs Market Key
    Developments
  • Major players in North America companion animal
    drugs market are focused on approval and launch
    of new products to expand their product
    portfolio. For instance, in September 2019,
    Zoetis Inc. received marketing authorization for
    Simparica Trio (sarolaner/moxidectin/pyrantel)
    chewable tablets for the treatment of mixed
    external and internal parasitic infestations in
    dogs, from the European Commission.
  • Similarly, in January 2018, Elanco Animal Health,
    a division of Eli Lilly and Company, received
    approaval for its product, Credelio (lotilaner),
    a small chewable tablet for dogs, for protection
    against ticks and fleas.

16
  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Buy Now
  • Reference https//www.coherentmarketinsights.com/
    market-insight/north-america-companion-animal-drug
    s-market-4117

17
About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

18
Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
    U.S.
  • Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

19
  • Thank You!
  • Kindly follow CMI Social Media
    Profiles for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
About PowerShow.com